europe-genetic-testing-market-industry
Published

August 2016

Europe Genetic Testing Market - Industry Analysis and Market Forecast (2016 - 2021)

Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license

The European genetic testing market accounted for USD 1.13 million in 2015 and is estimated to reach USD 1.22 billion in 2016. The market value is expected to reach USD 1.81 billion by 2021, growing at a CAGR of 8.2% during the forecast period.

Genetic testing has become quite prevalent in Europe over the last few years, with recent developments in molecular medicine expected to provide further impetus to this critical area. The integration of these technologies into the healthcare system necessitates that their application is implemented within a responsible framework of accompanying measures and activities.

As a consequence, genetic testing has been subjected to policy debates at various institutional and international levels. The European Commission has recognized certain salient topics involving genetic testing that need further clarity, including regional distribution of genetic services, suggestions for the rationalization of services, methods for improving national accreditation of genetic laboratories, long-term organization of external quality assessment, validation of next generation sequencing platforms and applications, and perspectives on direct-to-consumer genetic testing.

The report segments the market by type and geography. By type, the market is segmented into the carrier, diagnostic, newborn, predictive and presymptomatic, and prenatal testing. By geography, the market is segmented into Germany, France, Italy, the UK and the rest of Europe.

While Germany accounts for the largest share of the genetic testing market in Europe, the demand for these tests is likely to be the fastest growing in the United Kingdom during 2016-2021.

Some of the key players in Europe’s genetic testing market are:

  • Ariosa Diagnostics Inc.
  • Biocartis S.A.
  • Biohelix Corporation
  • Biomerieux SA
  • EKF Diagnostic Holdings PLC
  • Oxford Biodynamics Ltd.

Key Deliverables in the Study

  • Market analysis for Europe’s genetic testing market, with region-specific assessments and competition analysis on the global and regional scale.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market share.
  • Identification and analysis of the macro and micro factors that affect Europe’s genetic testing market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
  • In-depth analysis of the geographical and market factors that affect the growth of Europe’s genetic testing market.
  • Strategic assessment of indicators, market impact analysis, regional variation, current/ future market trends and profiles of major/niche global market participants.
RELATED REPORTS
No related reports available.
Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license
Our Clients Include View All

Looking to Customize Report?